medigraphic.com
Revista Médica Sinergia

2023, Number 02

<< Back Next >>

Revista Médica Sinergia 2023; 8 (02)

Incidence of metabolic syndrome in a patient with subclinical hypothyroidism, January 2019 - July 2022 in Ciudad Juárez

Silva AJ, Ruacho LRM

Language: Spanish
References: 26
Page:
PDF size: 231.23 Kb.


ABSTRACT

Introduction: Subclinical hypothyroidism, like metabolic syndrome, are considered important pathologies for medical practice. The first is an organic dysfunction of the thyroid gland and the other is insulin resistance and oxidative stress. The same that together are associated with important comorbidities in the patient affecting their quality of life.
Methods: In a total of 1402 consultations, between 2019 and 2022, 582 patients were studied, obtaining a total of 161 patients for the statistical sample. Evaluating them with the criteria of the latest BMJ and ATA guidelines respectively, studying the incidence of metabolic syndrome through clinical and biochemical parameters.
Results: It was distributed in two groups and 2 subgroups respectively, showing a higher incidence of patients with metabolic syndrome, compared to the general population. The mean age was (42 ± 12.519), group 2 (42.16 ± 12.875), without observing statistical differences (t=.119 and t=.266). They present a correlation (Rho spearman1=.108) and (Rho spearman2=-.90). A BMI (31.62 ± 7.96 kg/m2), group 2 (32.76 ± 6.59 kg/m2). Patients in treatment were analyzed with Fisher's exact test (f1= .355 and f2=.878) and a (RR of 1.97) on the risk of comorbidities compared to the population (p › 0.0001).
Conclusion: In the population, there is an important association between these pathologies and other comorbidities, reflecting the high prevalence of obesity, diabetes, and arterial hypertension in the face of the current condition of our country. Thus, explaining the importance of finding effective and adaptable therapies for our community.


REFERENCES

  1. Xu H, Li X, Adams H, Kubena K, Guo S. Etiology of Metabolic Syndrome and Dietary Intervention. International Journal of Molecular Sciences [Internet]. 2018, Dec 31;20(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337367/

  2. Belén LS, Maffei L, Alorda B, Squillace C, Rossi ML, Oliva ML, Torresani ME. Prevalencia de hipotiroidismo y su asociación con factores de riesgo cardiometabólicos en mujeres adultas argentinas. Rev Esp Nutr Hum Diet [Internet]. Setiembre, 2015 [citado el 21 de diciembre, 2022];19(3): 146-152. DOI: https://dx.doi.org/10.14306/renhyd.19.3.157

  3. Hernández JLC, González MJC, Galiana MA, Hernández EYR. Metabolic syndrome, a public health problem with different definitions and criteria. Revista Médica de la Universidad Veracruzana [Internet]. 2018, Feb 01 [cited 2021, Nov 25];17(2):7–24. Available from: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=76960

  4. Freeman AM, Pennings N. Insulin Resistance [Internet]. nih.gov. StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507839/

  5. Badri PR, Ahmed T, Takalkar AA. Prevalence of subclinical hypothyroidism in metabolic syndrome: our experience from Karnataka. International Journal of Advances in Medicine [Internet]. 2021, Aug 21 [cited 2022, Dec 21];8(9):1294–9. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/3119

  6. Yao JY, Liu P, Zhang W, Wang KW, Lyu CP, Zhang ZW, et al. Obesity rather than Metabolic Syndrome is a Risk Factor for Subclinical Hypothyroidism andThyroid Autoimmunity. Biomedical and environmental sciences: BES [Internet]. 2021, Oct 20 [cited 2022, Dec 21];34(10):819–23. Available from: https://pubmed.ncbi.nlm.nih.gov/34782048/

  7. Kim MD, Yang HJ, Kang NR, Park JH, Jung YE. Association between subclinical hypothyroidism and metabolic syndrome among individuals with depression. Journal of Affective Disorders. 2020, Mar;264:494–7.

  8. Liberman C. Enfermedad tiroidea subclínica: revisión y enfoque clínico. Revista Médica Clínica Las Condes [Internet]. 01 de setiembre, 2013;24(5):748-53. Disponible a partir de: https://www.sciencedirect.com/science/article/pii/S0716864013702190

  9. Brenta G, Caballero AS, Nunes MT. Case Finding For Hypothyroidism Should Include Type 2 Diabetes And Metabolic Syndrome Patients: A Latin American Thyroid Society (Lats) Position Statement. Endocrine Practice. 2019, Jan;25(1):101-5. DOI: 10.4158/EP-2018-0317

  10. Benvenga S, Pantano R, Saraceno G, Lipari L, Alibrando A, Inferrera S, et al. A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of l-thyroxine, may have metabolic and cardiovascular consequences. Journal of Clinical & Translational Endocrinology [Internet]. 2019, Jun 01 [cited 2022, Dec 21];16:100189. Available from: https://pubmed.ncbi.nlm.nih.gov/31011539/

  11. Dos Santos PF, Borges P, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome. Therapeutic Advances in Endocrinology and Metabolism [Internet]. 2020, May 13;11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238803/

  12. Garcia BF, da Veiga GL, Alves BCA, Gehrke FS, Fonseca FLA. Metabolic effects caused by sodium levothyroxine in subclinical hypothyroidism patients with low HDL. Obesity Medicine. 2019, Mar;13:26–8. DOI: https://doi.org/10.1016/j.obmed.2018.12.008

  13. Jin HY. Prevalence of subclinical hypothyroidism in obese children or adolescents and association between thyroid hormone and the components of metabolic syndrome. Journal of Paediatrics and Child Health. 2018, May 16;54(9):975–80. DOI: https://doi.org/10.1111/jpc.13926

  14. Mendoza-Romo MÁ, Ponce-Muñiz MR, Escudero-Lourdes GV, Ortiz-Nesme JF, Medina-Tinoco A, Fabela-Mendoza K, et al. Síndrome metabólico en pacientes mexicanos con hipotiroidismo. Revista de Endocrinología [Internet]. 2021 [citado el 21 dediciembre, 2022];8(1). Disponible a partir de: https://www.revistadeendocrinologia.com/frame_esp.php?id=210

  15. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports [Internet]. 2018, Feb;20(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866840/

  16. Feller M, Snel M, Moutzouri E, Bauer DC, de Montmollin M, Aujesky D, et al. Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism. JAMA [Internet]. 2018, Oct 02;320(13):1349–59. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233842/

  17. Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 2019, May 14;l2006. DOI: 10.1136/bmj.l2006

  18. Ding X, Zhao Y, Zhu C-Y, Wu L-P, Wang Y, Peng Z-Y, et al. The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies. Endocrine Journal. 2021;68(9):1043–56. DOI: 10.1507/endocrj.EJ20-0796

  19. Emiroğlu C, Özdemir Ç, Görpelioğlu S, Aypak C. The Relationship between Thyroid Hormones, Metabolic Syndrome and HOMA-IR in People with Obesity or Overweight. Clinical Diabetology [Internet]. 2022 [cited 2022, Dec 21];11(5):333–9. Available from: https://journals.viamedica.pl/clinical_diabetology/article/view/DK.a2022.0043

  20. Mohedano López E, Sanchís Osuna LM, González Vargas JM, Jiménez Hurtado R, Luque Romero LG. Características epidemiológicas del hipotiroidismo en un área del sur de España (Sevilla). Rev Clin Med Fam [Internet]. 2020 [citado el 21 de diciembre, 2022];13(2):123-130. Disponible a partir de: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2020000200004&lng=es.

  21. Quintanilla Ferrufino GJ, Medina Guillén LF, Erazo LC, Medina Guillén M, Shafick Asfúra J. Alteraciones cardiovasculares causadas por hipotiroidismo clínico y subclínico. Rev Cient Cienc Méd [Internet]. 2020 [citado el 20 de diciembre, 2022]; 23(1):52-60. Disponible a partir de: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332020000100008&lng=es.

  22. Trifu S. Thyroid Hormones as a Third Line of Augmentation Medication in Treatment-Resistant Depression. Acta Endocrinológica (Bucharest).2020;16(2):256–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535887/

  23. Inoue K, Ritz B, Brent GA, Ebrahimi R, Rhee CM, Leung AM. Association of Subclinical Hypothyroidism and Cardiovascular Disease With Mortality. JAMA Network Open [Internet]. 2020, Feb 05 [cited 2020, May 23];3(2):e1920745–5. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2760440

  24. Kim J, Prasitlumkum N, Randhawa S, Banerjee D. Association between Subclinical Hypothyroidism and Incident Hypertension in Women: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2021, Jul 28;10(15):3318. Available from: https://pubmed.ncbi.nlm.nih.gov/34362102/

  25. Raj D, Pooja F, Chhabria P, Kalpana F, Lohana S, Lal K, et al. Frequency of Subclinical Hypothyroidism in Women with Polycystic Ovary Syndrome. Cureus. 2021, Sep 04; DOI: 10.7759/cureus.17722.

  26. Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, Mateo-Gallego R, Casasnovas JA, Guallar-Castillon P, et al. Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome. Diabetes Care [Internet]. 2018, Dec 14 [cited 2019, May 27];42(2):303–10. Available from: http://care.diabetesjournals.org/content/42/2/3




2020     |     www.medigraphic.com